Fenofibrate/simvastatin
Fenofibrate/simvastatin, sold under the brand name Cholib, is a fixed-dose combination medication used to treat abnormal blood lipid levels when used in combination with a low-fat diet and exercise. It contains fenofibrate and simvastatin.

It was approved for use in the European Union in August 2013.
Q1779868
fixed-dose combination
Concept
Q419724
fenofibrate
Concept
Q670131
simvastatin
Concept
Q96377868
Fenofibrate/simvastatin
Concept
2013-08-01T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
August 2013
DATE
instance of